NCT02178579View on ClinicalTrials.gov

Prospective Observation of Cardiac Safety With Proteasome Inhibition

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 15, 2019

Study Completion Date

July 15, 2019

Conditions
Heart FailureMultiple Myeloma
Trial Locations (2)

37232

Vanderbilt University Medical Center, Nashville

19104-5159

University of Pennsylvania/Smilow Center for Translational Research, Philadelphia

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER